Results 351 to 360 of about 591,821 (395)

Assessing the Impact of Time to Diagnosis and Treatment for Patients With Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
DuBrock HM, Silvert E, Doddahonnaiah D, Murugadoss K, Wagner T, Lopez D, Sandros M.   +6 more
europepmc   +1 more source

Outcomes of Pulmonary Arterial Hypertension in Pregnancy: A Tertiary Care Retrospective Study. [PDF]

Cureus
Chopra S, Kaur A, Rai R, Sikka P, Aggarwal N, Suri V, Vijayvergiya R.   +6 more
europepmc   +1 more source

HNRNPA2B1: a novel target in pulmonary arterial hypertension. [PDF]

Front Cardiovasc Med
Wei Y, Wu D, Deng N, Xu F, Luo S, Fan X, Guo H, Chen J, Li W, Si X.   +9 more
europepmc   +1 more source

Pulmonary Arterial Hypertension.

New England Journal of Medicine, 2021
Copyright © 2021 Massachusetts Medical Society. Pulmonary hypertension is a syndrome characterized by marked remodeling of the pulmonary vasculature and a progressive rise in the pulmonary vascular load, leading to hypertrophy and remodeling of the right
P. Hassoun
semanticscholar   +8 more sources

Some of the next articles are maybe not open access.

Related searches:

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.

New England Journal of Medicine, 2023
BACKGROUND Pulmonary arterial hypertension is a progressive disease involving proliferative remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated morbidity and mortality remain high.
M. Hoeper, D. Badesch, H. Ghofrani, J. Gibbs, M. Gomberg-Maitland, V. McLaughlin, I. Preston, R. Souza, A. Waxman, E. Grünig, G. Kopeć, G. Meyer, K. Olsson, Stephan Rosenkranz, Yayun Xu, B. Miller, Marcie Fowler, J. Butler, J. Koglin, J. de Oliveira Pena, M. Humbert   +20 more
semanticscholar   +1 more source

Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.

Journal of the American Medical Association (JAMA), 2022
Importance Pulmonary arterial hypertension (PAH) is a subtype of pulmonary hypertension (PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is approximately 10.6 cases per 1 million adults in the US.
N. Ruopp, B. Cockrill
semanticscholar   +1 more source

Molecular genetic framework underlying pulmonary arterial hypertension

Nature Reviews Cardiology, 2019
Laura Southgate, Rajiv D Machado, Stefan Gräf   +2 more
exaly   +2 more sources

Pulmonary arterial hypertension

Medicina Clínica (English Edition), 2022
Pulmonary arterial hypertension (PAH) is a rare disease characterized by adverse remodeling of the arterial tree leading to increased vascular resistance with subsequent increase in right ventricular afterload and eventual development of heart failure.
Raquel, Luna-López, Alicia, Ruiz Martín, Pilar, Escribano Subías   +2 more
openaire   +2 more sources